Psilocybin study for healthy volunteers
Treatments studied
Part of Mental health clinical trials.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 70 years old
- You can read and speak English fluently
- You can swallow pills or capsules
- If you can become pregnant, you must use effective birth control and not be breastfeeding
- You have a support person to accompany you home after dosing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.
This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
Hear when a new Healthy Participants With Lower-than-average Mental Well-being trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.